Literature DB >> 4031057

Apolipoprotein B-100 deficiency. Intestinal steatosis despite apolipoprotein B-48 synthesis.

P N Herbert, J S Hyams, D N Bernier, M M Berman, A L Saritelli, K M Lynch, A V Nichols, T M Forte.   

Abstract

We describe a child, the issue of phenotypically normal parents, who had fat malabsorption, both intestinal and hepatic steatosis, and serum cholesterol and triglyceride concentrations of 38 and 63 mg/dl, respectively. Lipoprotein electrophoresis, Ouchterlony double diffusion, and electron microscopy demonstrated that normal low density lipoproteins (LDL: 1.006 less than rho less than 1.063 g/ml) were absent. Lipoprotein particles in the rho less than 1.006-g/ml fraction were triglyceride rich, very large (93.2 +/- 35.1 nm), and contained the B-48 but not the B-100 apoprotein; both species of apolipoprotein (apo) B were found in the parents' lipoproteins. These chylomicrons and chylomicron remnants were present even in the patient's fasting plasma, which suggested prolonged dietary fat absorption. Plasma levels of high density lipoprotein lipids and proteins were low, and the phosphatidylcholine/sphingomyelin ratio was reduced as in typical abetalipoproteinemia. The monosialylated form of apo C-III was not identified on polyacrylamide gel electrophoresis, which suggested that this protein was elaborated only with very low density lipoproteins (VLDL). A radioimmunoassay for apo B employing a polyclonal antisera to plasma LDL gave apparent plasma apo B levels of 0.6, 66, and 57 mg/dl in the patient and his father and mother, respectively. The displacement curve generated by the parents' VLDL and LDL did not did not differ from control lipoproteins. The patient's chylomicron-chylomicron remnant fraction displaced normal LDL over the entire radioimmunoassay range, but the efficiency of displacement was strikingly less than with B-100 containing lipoproteins. If the patient's B-48 protein is not qualitatively abnormal, these results confirm very limited immunochemical cross-reactivity between at least one major epitope on B-100 and the epitopes expressed on B-48. The apo B defect in this patient appears to be recessive. It abolishes B-100 production and may additionally limit the formation of B-48.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031057      PMCID: PMC423826          DOI: 10.1172/JCI111986

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

Review 2.  Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays.

Authors:  D Rodbard
Journal:  Clin Chem       Date:  1974-10       Impact factor: 8.327

3.  Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons.

Authors:  J P Kane; D A Hardman; H E Paulus
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

4.  Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.

Authors:  G Heiss; I Tamir; C E Davis; H A Tyroler; B M Rifkand; G Schonfeld; D Jacobs; I D Frantz
Journal:  Circulation       Date:  1980-02       Impact factor: 29.690

5.  Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypolphalipoproteinemia and fasting chylomicronemia.

Authors:  D Steinberg; S M Grundy; H Y Mok; J D Turner; D B Weinstein; W V Brown; J J Albers
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

6.  Metabolic heterogeneity of apolipoprotein B in the rat.

Authors:  C E Sparks; J B Marsh
Journal:  J Lipid Res       Date:  1981-03       Impact factor: 5.922

7.  Variant forms of plasma apolipoprotein B. Hepatic and intestinal biosynthesis and heterogeneous metabolism in the rat.

Authors:  A L Wu; H G Windmueller
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

8.  Apolipoprotein B is structurally and metabolically heterogeneous in the rat.

Authors:  J Elovson; Y O Huang; N Baker; R Kannan
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

9.  Apolipoprotein B variant derived from rat intestine.

Authors:  K V Krishnaiah; L F Walker; J Borensztajn; G Schonfeld; G S Getz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein.

Authors:  M J Malloy; J P Kane; D A Hardman; R L Hamilton; K B Dalal
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

View more
  8 in total

1.  Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia.

Authors:  R P Dullaart; B Speelberg; H J Schuurman; R W Milne; L M Havekes; Y L Marcel; H J Geuze; M M Hulshof; D W Erkelens
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

2.  Regulation of hepatic lipase activity by sphingomyelin in plasma lipoproteins.

Authors:  Peng Yang; Papasani V Subbaiah
Journal:  Biochim Biophys Acta       Date:  2015-07-18

3.  Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100.

Authors:  S G Young; S J Bertics; L K Curtiss; B W Dubois; J L Witztum
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

4.  Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia.

Authors:  S G Young; S J Bertics; L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

5.  Apolipoprotein B synthesis by human liver and intestine in vitro.

Authors:  R M Glickman; M Rogers; J N Glickman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Rat intestinal apolipoprotein B gene expression. Evidence for integrated regulation by bile salt, fatty acid, and phospholipid flux.

Authors:  N O Davidson; M J Drewek; J I Gordon; J Elovson
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

7.  Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis.

Authors:  Mindy C W Lam; Janakie Singham; Robert A Hegele; Maziar Riazy; Matti A Hiob; Gordon Francis; Urs P Steinbrecher
Journal:  Case Rep Gastroenterol       Date:  2012-07-03

Review 8.  Sphingomyelin in high-density lipoproteins: structural role and biological function.

Authors:  Roberto Martínez-Beamonte; Jose M Lou-Bonafonte; María V Martínez-Gracia; Jesús Osada
Journal:  Int J Mol Sci       Date:  2013-04-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.